Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Satellos Bioscience Inc. (MSLE) had Cash Flow from Investing Activities of $-6.86M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.82M |
|
-- |
|
-- |
|
$5.97M |
|
$-5.97M |
|
$0.16M |
|
$-5.80M |
|
$-5.80M |
|
$-5.82M |
|
$-5.82M |
|
$-5.82M |
|
$-5.82M |
|
$-5.97M |
|
$-5.96M |
|
13.94M |
|
13.94M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$37.50M |
|
$0.01M |
|
$0.01M |
|
$37.50M |
|
$3.50M |
|
-- |
|
-- |
|
$3.50M |
|
$34.00M |
|
$34.00M |
|
$34.00M |
|
15.42M |
|
| Cash Flow Statement Financials | |
$-16.34M |
|
|
Cash Flow from Investing Activities |
$-6.86M |
$2.09M |
|
$40.07M |
|
$19.30M |
|
$-20.77M |
|
$2.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.12% |
|
-17.12% |
|
-15.52% |
|
-17.12% |
|
$2.21 |
|
$-1.17 |
|
$-1.17 |
|